Biotech entity
clinical-trial accounts for 4 of the 5 tracked stories, while 1 other category carries the remainder. Uganda is most often covered alongside World Health Organization, which appears in 4 of these 5 stories. Negative sentiment reaches 80% here, compared with 27% across the 154-story beat baseline for the same window.
Last mentioned: Aug 13, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 60 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
clinical-trial accounts for 4 of the 5 tracked stories, while 1 other category carries the remainder. Uganda is most often covered alongside World Health Organization, which appears in 4 of these 5 stories. Negative sentiment reaches 80% here, compared with 27% across the 154-story beat baseline for the same window. At 8, the average consequence score sits above the same-window beat average of 6.4. That works out to roughly 1.4 stories per week across a 25-day span. They are less corroborated than the beat average, carrying 3.8 original sources each against 4.5 for the same window. This profile follows 5 Biotech stories mentioning Uganda across the period from July 11, 2026 to August 4, 2026.
Computed from the 5 stories linked to this entity, with beat comparisons drawn from all 154 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Uganda. Shared-story counts are live from our verified record — not editorial picks.
Leadership Visits and Latest Data Released
Africa CDC Director-General Jean Kaseya visited Bunia, WHO Director-General Tedros arrived in Kinshasa; government update reported 3,802 cases and 1,707 deaths.
Healthcare Workers Issue Ultimatum
In Mongbwalu, healthcare workers threatened to escalate action within 24 hours if unpaid wages were not resolved.
WHO sounds alarm
WHO reports that 80% of new cases are from unknown chains of transmission; striking workers agree to return if paid within 72 hours.
Health worker strike
Dozens of healthcare workers at an Ebola treatment centre in Bunia go on strike over unpaid salaries and bonuses.
Record outbreak data confirmed
Africa CDC reports the outbreak as the fastest-growing ever at 1,830 confirmed cases and 648 deaths. U.S. aid worker infection announced by CDC.
Clinical trials for treatments launched
Researchers initiate a highly anticipated clinical study to test experimental therapies against the Bundibugyo virus.
Kenya court suspends U.S.-backed facility
A Kenyan court order halts construction of a U.S.-planned quarantine facility for Americans exposed abroad, complicating evacuation plans.
Uganda Declared Ebola‑Free
Neighboring Uganda discharged its last Ebola patient, ending its own transmission chain linked to the Congo outbreak.
Ebola outbreak officially declared
Congolese authorities declare a fresh Ebola outbreak after weeks of undetected transmission, as later confirmed by WHO.
Outbreak identified
Congo detects an outbreak of the rare Bundibugyo Ebola virus in the eastern part of the country.
First U.S. doctor infected and evacuated
An American doctor working in Congo tests positive for Ebola and is transferred to Germany for treatment during the outbreak’s first week.
Congo’s Bundibugyo Ebola outbreak has surged to 3,802 cases and 1,707 deaths, highlighting an urgent need for vaccines and treatments. With no approved products available, two post‑exposure prophylaxis trials in Ituri and two vaccine trials in the UK and Canada are now underway, while nearly 80% of new cases elude contact tracing.
Source: wfmj.com · orlandosentinel.com
With no approved vaccine or treatment, the rare Bundibugyo ebolavirus driving the Congo outbreak has infected 1,830 people and killed 648. As two U.S. workers fall ill, recently launched clinical trials represent the only hope for a therapeutic breakthrough.
Source: wtvq.com
With 80% of new Ebola cases from unknown chains and the rare Bundibugyo strain lacking any approved vaccine or treatment, this outbreak exposes a critical gap in the biopharma pipeline and may catalyse urgent R&D investment.
75 healthcare workers infected with the Ebola Bundibugyo strain in DRC expose critical gaps in vaccine coverage and trial infrastructure, pressuring biopharma to accelerate strain-specific countermeasures.
Source: yahoo.com · medscape.com
With no approved therapies for the Bundibugyo Ebola strain and an outbreak surpassing 500 fatalities, two candidate drugs have begun a clinical trial, and a prophylactic agent trial is imminent. The collaborative effort signals a pivot toward rapid, integrated R&D for neglected filoviruses.
Uganda is linked from 5 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
